BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
SMS Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532815
ISIN Demat
INE812G01025
Book Value (Rs)
85.9335567
NSE Symbol
SMSPHARMA
Divident Yield %
0.11
Market Cap
(Rs In Cr.)
3,533
P/E (TTM)
39.02
EPS (TTM)
9.67
Face Value
(Rs)
1
Back
SMS Pharmaceuticals consolidated net profit rises 2.05% in the June 2026 quarter
01-Aug-26   Hrs IST

Net profit of SMS Pharmaceuticals rose 2.05% to Rs 20.91 crore in the quarter ended June 2026 as against Rs 20.49 crore during the previous quarter ended June 2025. Sales rose 5.56% to Rs 206.96 crore in the quarter ended June 2026 as against Rs 196.05 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales206.96196.05 6
OPM %19.7920.08 -
PBDT37.2034.12 9
PBT27.2124.37 12
NP20.9120.49 2

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)